Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Warren › NPI 1659360220
Hospital

Warren General Hospital

Warren General Hospital was paid $3.80M by Medicaid between Jan 2018 and Dec 2024, across 184 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.

33Billing provider infoWARREN GENERAL HOSPITAL
WARREN, PA 16365
33aNPI1659360220assigned 10/17/2005
28Total paid$3.80M
24GClaims152,177
24DCodes billed184
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201854$206.66
2019438$2K
202012,527$175K
202168,397$1.38M
202225,615$966K
202324,405$724K
2024incomplete20,741$548K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 16% 9,702 9,404 $594K
G0378 Hospital observation service, per hour 12% 502 462 $444K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 11% 5,000 4,808 $421K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 8.8% 4,182 4,086 $335K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 7.6% 3,933 3,794 $290K
87634 6.5% 4,191 4,095 $247K
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 6.4% 7,035 2,063 $242K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2.2% 2,886 2,746 $83K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.1% 1,201 1,107 $81K
80053 Comprehensive metabolic panel 2.0% 8,973 7,687 $76K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.5% 431 413 $58K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.5% 1,153 1,027 $56K
172 more codes
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.4% 2,057 $52K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.3% 11,815 $50K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1.3% 2,587 $48K
80050 General health panel 1.2% 1,021 $45K
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel <1% 1,351 $37K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 3,816 $27K
71046 Radiologic examination, chest; 2 views <1% 2,127 $26K
80061 Lipid panel <1% 2,114 $26K
80048 Basic metabolic panel (calcium, ionized) <1% 3,638 $24K
70450 Computed tomography, head or brain; without contrast material <1% 468 $23K
83735 <1% 4,875 $23K
81000 <1% 6,268 $21K
84484 <1% 3,004 $20K
77067 Screening mammography, bilateral, including computer-aided detection <1% 241 $18K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 341 $16K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 248 $15K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 732 $15K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 202 $15K
84443 Thyroid stimulating hormone (TSH) <1% 859 $15K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 697 $15K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 427 $14K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 620 $11K
71275 Computed tomographic angiography, chest, with contrast material <1% 86 $10K
80076 <1% 1,366 $10K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,419 $9K
97161 <1% 238 $9K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 3,191 $9K
96375 Therapeutic injection; each additional sequential IV push <1% 760 $9K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 359 $9K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 355 $9K
94760 <1% 5,111 $8K
96361 Intravenous infusion, hydration; each additional hour <1% 817 $8K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 143 $7K
83036 Hemoglobin; glycosylated (A1C) <1% 1,197 $7K
83690 <1% 1,727 $7K
87040 <1% 672 $7K
87088 <1% 930 $6K
87070 <1% 869 $6K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 900 $6K
83605 <1% 1,071 $6K
77063 Screening digital breast tomosynthesis, bilateral <1% 241 $5K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 111 $5K
82728 <1% 531 $5K
84481 <1% 192 $5K
73564 <1% 278 $5K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 401 $5K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 155 $5K
72125 Computed tomography, cervical spine; without contrast material <1% 99 $5K
71045 Radiologic examination, chest; single view <1% 860 $4K
83880 <1% 264 $4K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 278 $4K
86885 <1% 515 $4K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 774 $4K
84703 <1% 413 $4K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 25 $3K
82607 <1% 310 $3K
84439 <1% 443 $3K
88142 <1% 181 $3K
73630 <1% 281 $3K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 70 $3K
85379 <1% 378 $3K
87186 <1% 387 $3K
73030 <1% 187 $3K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 86 $3K
73610 <1% 170 $3K
87077 <1% 438 $3K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 12 $3K
0011A <1% 79 $2K
86618 <1% 117 $2K
84702 <1% 146 $2K
87430 <1% 335 $2K
73110 <1% 225 $2K
85610 <1% 820 $2K
85730 <1% 438 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 31 $2K
86900 <1% 531 $2K
82043 <1% 266 $2K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 69 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 51 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 370 $2K
72110 <1% 106 $2K
73502 <1% 107 $2K
83540 <1% 264 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 128 $2K
84436 <1% 200 $2K
71250 <1% 31 $2K
86901 <1% 428 $2K
84466 <1% 113 $1K
73130 <1% 129 $1K
97165 <1% 38 $1K
36415 Collection of venous blood by venipuncture <1% 8,398 $1K
0012A <1% 28 $1K
82248 <1% 171 $1K
96376 <1% 337 $1K
84550 <1% 217 $1K
86592 <1% 259 $1K
85651 <1% 413 $997.56
86480 <1% 14 $992.13
84153 <1% 40 $964.16
X0592 <1% 154 $933.42
84479 <1% 109 $926.90
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 252 $879.80
96367 <1% 49 $835.88
81025 <1% 243 $829.60
74018 <1% 74 $802.42
84146 <1% 29 $744.39
86038 <1% 57 $744.19
36591 <1% 348 $638.82
82652 <1% 12 $629.24
83615 <1% 118 $620.12
93971 <1% 16 $614.68
97597 <1% 26 $610.56
V2020 Frames, purchases <1% 12 $591.96
76801 <1% 15 $585.06
76830 Ultrasound, transvaginal <1% 17 $580.49
76775 <1% 18 $538.81
93226 <1% 13 $513.74
82565 <1% 87 $503.75
0001A <1% 14 $480.00
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 27 $476.32
90715 <1% 24 $437.72
99213 Doctor's office visit, returning patient (routine) <1% 16 $420.00
86140 <1% 143 $381.20
72052 <1% 13 $356.50
76642 <1% 12 $354.52
84460 <1% 53 $341.67
83550 <1% 87 $339.83
82746 <1% 39 $326.99
88174 <1% 12 $312.85
J2704 Injection, propofol, 10 mg <1% 522 $278.20
84520 <1% 50 $245.70
93225 <1% 13 $237.07
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 26 $202.50
86803 <1% 12 $186.20
73080 <1% 17 $179.80
82962 <1% 244 $174.02
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 34 $172.48
86430 <1% 27 $165.36
87340 <1% 14 $153.06
84450 <1% 28 $148.25
82247 <1% 22 $142.71
74019 <1% 12 $141.08
87081 <1% 24 $119.60
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 850 $117.79
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 193 $117.00
82803 <1% 17 $114.97
J2270 Injection, morphine sulfate, up to 10 mg <1% 177 $101.36
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 696 $101.29
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 588 $95.89
82550 <1% 14 $92.04
J1170 Injection, hydromorphone, up to 4 mg <1% 222 $83.34
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 382 $80.34
20610 <1% 52 $73.61
82140 <1% 13 $58.00
94664 <1% 16 $50.82
J3010 Injection, fentanyl citrate, 0.1 mg <1% 348 $43.26
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,129 $42.87
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 186 $26.43
G0008 Administration of influenza virus vaccine <1% 47 $22.24
J0690 Injection, cefazolin sodium, 500 mg <1% 65 $14.28
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 43 $11.31
93041 <1% 131 $10.94
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 299 $10.41
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 454 $6.52
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 33 $2.32
90662 <1% 19 $1.19
91301 <1% 98 $0.82
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 0% 15 $0.00
3049F 0% 13 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 27 $0.00
3050F 0% 13 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSNYDER, JULIE (EXEC. DIRECTOR OF FINANCE)
Same official

Other billing entities under SNYDER, JULIE

Full network →
ProviderLocationPaid
Warren General HospitalWarren, PA$280K
Warren General HospitalWarren, PA$12K
Warren General HospitalWarren, PA$11K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.